George Milne

Dr. George M.
Milne is a Chairman at Amylyx Pharmaceuticals, Inc., a Venture Partner at Radius Ventures LLC, an Independent Director at Charles River Laboratories, Inc. and a Chairman at Mystic Aquarium & Institute for Exploration.
He is on the Board of Directors at Sea Research Foundation, Inc., Charles River Laboratories, Inc. and The New York Botanical Garden.
Dr. Milne was previously employed as a Chairman by Aurinia Pharmaceuticals, Inc., a Lead Director by Aspreva Pharmaceuticals Corp., a Chairman by Melinta Therapeutics, Inc. /Old/, an Independent Director by BTHC VI, Inc, a Lead Independent Director by Charles River Laboratories International, Inc., an Independent Director by Mettler-Toledo International, Inc., a President-Central Research by Pfizer Inc., and an Independent Director by QLT, Inc. He also served on the board at The Charles Stark Draper Laboratory, Inc., BTHC VI, Inc., BioStorage Technologies, Inc., MedImmune LLC, Conor Medsystems LLC, Mettler Toledo, Inc. and Resolvyx Pharmaceuticals, Inc. He received his undergraduate degree from Yale University and a doctorate degree from Massachusetts Institute of Technology.